Optimi Health Corp. (OPTH)
Sector: Pharmaceutical Preparations
Industry: Drug Manufacturers - Specialty & Generic
Optimi Health Corp.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 9, 2026 | 2.34 | 2.54 | 2.15 | 2.50 | 32,789 |
| Nov 6, 2026 | 2.41 | 2.41 | 2.25 | 2.34 | 18,328 |
| Nov 5, 2026 | 2.14 | 2.42 | 2.10 | 2.39 | 86,755 |
| Nov 4, 2026 | 2.11 | 2.30 | 1.90 | 2.21 | 99,867 |
| Nov 3, 2026 | 2.21 | 2.44 | 2.05 | 2.11 | 79,548 |
| Nov 2, 2026 | 2.49 | 2.62 | 2.11 | 2.24 | 21,763 |
| Oct 30, 2026 | 2.58 | 2.65 | 2.02 | 2.41 | 59,326 |
| Oct 29, 2026 | 2.80 | 2.94 | 2.55 | 2.60 | 55,098 |
| Oct 28, 2026 | 3.10 | 3.16 | 2.78 | 2.79 | 28,053 |
| Oct 27, 2026 | 3.12 | 3.16 | 3.01 | 3.04 | 12,675 |
| Oct 26, 2026 | 3.16 | 3.30 | 3.10 | 3.12 | 11,332 |
| Oct 23, 2026 | 3.28 | 3.37 | 3.16 | 3.25 | 6,248 |
| Oct 22, 2026 | 3.60 | 3.60 | 3.28 | 3.28 | 20,541 |
| Oct 21, 2026 | 3.49 | 3.58 | 3.27 | 3.53 | 18,729 |
| Oct 20, 2026 | 3.31 | 3.51 | 3.28 | 3.36 | 18,429 |
| Oct 19, 2026 | 3.47 | 3.74 | 3.25 | 3.33 | 18,885 |
| Oct 16, 2026 | 3.19 | 3.47 | 3.19 | 3.38 | 19,947 |
| Oct 15, 2026 | 3.24 | 3.44 | 3.05 | 3.19 | 34,948 |
| Oct 14, 2026 | 3.54 | 3.54 | 3.04 | 3.17 | 54,636 |
| Oct 13, 2026 | 3.55 | 3.67 | 3.31 | 3.50 | 34,596 |
| Name | Shares | % | Source |
|---|---|---|---|
AdvisorShares Investments LLC | 260.4K | 4.5% | 13F |
Yorkville Advisors Global, LP | 199.0K | 3.5% | 13F |
YA II PN, Ltd. · also on 13F· joint filing· may incl. warrants· filed Oct 2026 | 173.0K | 3.0% | 13G |
Mariner, LLC | 122.3K | 2.1% | 13F |
StoneX Group Inc. | 11.0K | 0.2% | 13F |
TWO SIGMA SECURITIES, LLC | 10.6K | 0.2% | 13F |
UBS Group AG | 5.9K | 0.1% | 13F |
ROYAL BANK OF CANADA | 2.0K | 0.0% | 13F |
NATIONAL BANK OF CANADA /FI/ | 598 | 0.0% | 13F |
TD Waterhouse Canada Inc. | 333 | 0.0% | 13F |
Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products.
The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.
based on 5.73M shares outstanding
30d Avg
36.55K
60d Avg
40.41K
90d Avg
42.05K